News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Trump and Xi will meet next week on the APEC sidelines in Shenzhen.
  • White House officials say Trump will not raise the Alice Huang national security case during the meeting.
  • Administration says investigations will be kept separate from high-level diplomacy to avoid complicating talks.
  • Two Democratic senators ordered SpaceX to preserve records on alleged Starlink service limits to Ukraine.
  • Request seeks communications and internal documents since Sept 1 and requires Nov 30 confirmation of preservation.
  • Lawmakers link the alleged Starlink limits to operational disruptions in Ukraine in October and November, signaling a probe.

Latest Articles

Anthropic Readies IPO Prospectus for Release After Labor Day, Eyes Late September or Early October Listing

Anthropic Readies IPO Prospectus for Release After Labor Day, Eyes Late September or Early October Listing

Anthropic plans to make its IPO prospectus public after Labor Day, with a potential market debut targeted for late September or early October. The firm, which confidentially filed earlier this year, is weighing whether to permit existing shareholders to sell in the offering and is considering lockup periods longer than the typical 180 days. The com…

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Biohaven shares trade near $15.90 after a pullback; a recently announced Opakalim licensing deal for epilepsy (terms limited) plus multiple 2026 clinical readouts and a still-meaningful cash position support a mid-term, catalyst-driven long. Market cap (~$2.4B), negative EPS (-$4.29), and steep cash burn keep this as a high-risk trade with clearly …

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile remains the most aggressive and efficient U.S. wireless operator: double-digit service revenue growth, strong free cash flow, a 2.2% yield and an attractive EV/EBITDA multiple. After Q2 volatility and a near-term ex-dividend, the stock offers a defined-risk entry for a mid-term swing trade targeting a re-rating toward prior trading ranges.

Synopsys Q3 Review: Strong Beats, Integration Progress, and the Road Ahead

Synopsys Q3 Review: Strong Beats, Integration Progress, and the Road Ahead

Synopsys reported Q3 FY2026 revenue of $2.477 billion, a 42% year-over-year increase and $37 million above expectations, with non-GAAP EPS of $3.91 versus $3.67 estimated. The company raised full-year guidance, disclosed accelerating Ansys integration progress and synergy targets, and highlighted AI-driven efficiency gains. Despite the beat, shares…

UPDATE -- Canada-Japan Support Advances Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research

UPDATE -- Canada-Japan Support Advances Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research

Xanadu Quantum Technologies and Mitsubishi Chemical have entered the next phase of their collaboration to develop quantum computing algorithms aimed at improving extreme ultraviolet (EUV) lithography for semiconductor manufacturing. Supported by innovation programs from Canada and Japan, the partnership focuses on creating a quantum-ready software …